Please enable JS

News

News

Decentralised clinical trials (DCTs): protect your data to reduce risk

June 22, 2023

Biopharma Dive Many professionals in the life sciences industry are excited about the benefits decentralised clinical trials (DCTs) bring to the clinical research process and specifically to patients. The use of wearables, electronic consent forms, digital outcomes assessments, and other DCT technologies are transforming how we gather clinical data and interact with study participants. However, […]

READ MORE

News

Yoanni Matsakis President of Telemedicine Technologies at the upcoming ๐‡๐€๐‚๐‘๐Ž ๐‚๐‹๐ˆ๐๐ˆ๐‚๐€๐‹ ๐“๐‘๐ˆ๐€๐‹๐’ ๐…๐Ž๐‘๐”๐Œ

June 7, 2023

Yoani Matsakisย President ofย Telemedicine Technologiesย will be delivering an engaging speech at the upcoming “๐‡๐€๐‚๐‘๐Ž [๐‡๐ž๐ฅ๐ฅ๐ž๐ง๐ข๐œ ๐€๐ฌ๐ฌ๐จ๐œ๐ข๐š๐ญ๐ข๐จ๐ง ๐จ๐Ÿ ๐‚๐‘๐Ž๐ฌ] ๐‚๐‹๐ˆ๐๐ˆ๐‚๐€๐‹ ๐“๐‘๐ˆ๐€๐‹๐’ ๐…๐Ž๐‘๐”๐Œ โ€“ ๐ƒ๐ž๐ฏ๐ž๐ฅ๐จ๐ฉ๐ฆ๐ž๐ง๐ญ๐ฌ ๐š๐ง๐ ๐๐ž๐ซ๐ฌ๐ฉ๐ž๐œ๐ญ๐ข๐ฏ๐ž๐ฌ” ๐จ๐ง ๐‰๐ฎ๐ง๐ž ๐Ÿ–๐ญ๐ก at the prestigious Divani Caravel Hotel in Athens, Greece. Mr. Matsakis’s speech, titled “๐™๐™๐™š ๐™€๐™๐˜พ๐™๐™Š๐™ ๐™‚๐˜ฟ๐™‹๐™ ๐˜พ๐™ค๐™™๐™š ๐™ค๐™› ๐˜พ๐™ค๐™ฃ๐™™๐™ช๐™˜๐™ฉ ๐™›๐™ค๐™ง ๐˜พ๐™ก๐™ž๐™ฃ๐™ž๐™˜๐™–๐™ก ๐™๐™š๐™จ๐™š๐™–๐™ง๐™˜๐™, ๐™ฌ๐™๐™š๐™ง๐™š ๐™–๐™ง๐™š ๐™ฌ๐™š, ๐™–๐™ฃ๐™™ ๐™ฌ๐™๐™–๐™ฉ ๐™˜๐™–๐™ฃ […]

READ MORE

News

Telemedicine Technologies will be present at SantEXPO Paris – E41

May 22, 2023

Wednesday may 24 TELEMEDICINE TECHNOLOGIES will be present at SantExpo on the OVHcloud stand as a partner of the “Open Trusted Cloud” program. Our president Yoani Matsakis will be representing Telemedicine Technologies, and wil intervene next toย Mathieu Godart, CTO and co-founder of SรŠMEIA and Emmanuel MEYRIEUX, Client Security manager at OVHcloud. Throughout the day you […]

READ MORE

News

Pfizer’s maternal RSV vaccine appears to win over FDA ahead of advisory meeting

May 22, 2023

Fierce Biotech The FDA seems to be satisfied that Pfizer’s RSV vaccine is safe and effective for administration in pregnant women to protect infants from severe disease. The agencyโ€™s confidence was revealed in briefing documents filed ahead of an advisory committee meeting set for Thursday. The Vaccines and Related Biological Products Advisory Committee will consider […]

READ MORE

Categories

News